Clinical trial
Effect of Rosiglitazone on In-vivo Angiogenic Potential of Human Adipose Tissue
NCT01150981 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Rosiglitazone on In-vivo Angiogenic Potential of Human Adipose Tissue
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- April 30, 2010
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.